Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1148/radiol.2361040312
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jacobs, M. A.
Right arrow Articles by Kim, H. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jacobs, M. A.
Right arrow Articles by Kim, H. S.
(Radiology 2005;236:196-203.)
© RSNA, 2005


Genitourinary Imaging

Uterine Fibroids: Diffusion-weighted MR Imaging for Monitoring Therapy with Focused Ultrasound Surgery—Preliminary Study1

Michael A. Jacobs, PhD, Edward H. Herskovits, MD, PhD and Hyun S. Kim, MD

1 From the Russell H. Morgan Department of Radiology and Radiological Science (M.A.J., H.S.K.) and Department of Vascular and Interventional Radiology (H.S.K.), the Johns Hopkins University School of Medicine, Traylor Bldg, Room 217, 712 Rutland Ave, Baltimore, MD 21205; and Department of Radiology, University of Pennsylvania, Philadelphia, Pa (E.H.H.). Received February 17, 2004; revision requested April 23; revision received August 24; accepted October 20. M.A.J. supported in part by National Institutes of Health grants P50 CA09630 and 1R01CA100184. Address correspondence to M.A.J. (e-mail: mikej{at}mri.jhu.edu).

PURPOSE: To prospectively determine the feasibility of using diffusion-weighted (DW) imaging and apparent diffusion coefficient (ADC) mapping before (baseline) and after treatment and at 6-month follow-up to monitor magnetic resonance (MR) image–guided focused ultrasound surgical ablation of uterine fibroids.

MATERIALS AND METHODS: Informed consent was obtained from patients before treatment with our study protocol, as approved by the institutional review board, and the study complied with the Health Insurance Portability and Accountability Act. Fourteen patients (mean age, 46 years ± 5 [standard deviation]) who underwent DW imaging were enrolled in this study, and 12 of 14 completed the inclusive MR examination with DW imaging at 6-month follow-up. Treatment was performed by one radiologist with a modified MR image–guided focused ultrasound surgical system coupled with a 1.5-T MR imager. Pre- and posttreatment and 6-month follow-up MR images were obtained by using phase-sensitive T1-weighted fast spoiled gradient-recalled acquisition, T1-weighted contrast material–enhanced, and DW imaging sequences. Total treatment time was 1–3 hours. Trace ADC maps were constructed for quantitative analysis. Regions of interest localized to areas of hyperintensity on DW images were drawn on postcontrast images, and quantitative statistics were obtained from treated and nontreated uterine tissue before and after treatment and at 6-month follow-up. Statistical analysis was performed with analysis of variance. Differences with P < .05 were considered statistically significant.

RESULTS: T1-weighted contrast-enhancing fibroids selected for treatment had no hyperintense or hypointense signal intensity changes on the DW images or ADC maps before treatment. Considerably increased signal intensity changes that were localized within the treated areas were noted on DW images. Mean baseline ADC value in fibroids was 1504 mm–6/sec2 ± 290. Posttreatment ADC values for nontreated fibroid tissue (1685 mm–6/sec2 ± 468) differed from posttreatment ADC values for fibroid tissue (1078 mm–6/sec2 ± 293) (P = .001). A significant difference (P < .001) between ADC values for treated (1905 mm–6/sec2 ± 446) and nontreated (1437 mm–6/sec2 ± 270) fibroid tissue at 6-month follow-up was observed.

CONCLUSION: DW imaging and ADC mapping are feasible for identification of ablated tissue after focused ultrasound treatment of uterine fibroids.

© RSNA, 2005




This article has been cited by other articles:


Home page
JCOHome page
D. A. Hamstra, A. Rehemtulla, and B. D. Ross
Diffusion Magnetic Resonance Imaging: A Biomarker for Treatment Response in Oncology
J. Clin. Oncol., September 10, 2007; 25(26): 4104 - 4109.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
M. A. Jacobs, T. S. Ibrahim, and R. Ouwerkerk
AAPM/RSNA Physics Tutorials AAPM/RSNA Physics Tutorials for Residents: MR Imaging: Brief Overview and Emerging Applications
RadioGraphics, July 1, 2007; 27(4): 1213 - 1229.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 2005 by the Radiological Society of North America.